- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: non-alcoholic fatty liver disease
Total 386320 results
-
Hasselt UniversityActive, not recruiting
-
HaEmek Medical Center, IsraelCompletedNon-alcoholic Fatty Liver Disease | Liver FibrosisIsrael
-
Guangzhou Medical UniversityAffiliated Hospital of Guangdong Medical UniversityCompletedNonalcoholic Fatty Liver DiseaseChina
-
Cairo UniversityCompletedPost Operative Pain, AcuteEgypt
-
Gilead SciencesNovo Nordisk A/SActive, not recruitingNonalcoholic SteatohepatitisUnited States, Spain, Australia, France, Japan, Puerto Rico, Canada
-
Grand Valley State UniversityEnrolling by invitationMetabolic Associated-dysfunction Steatotic Liver Disease (MASLD) | Metabolic Associated-dysfunction Steatohepatitis (MASH)United States
-
Fundació EurecatCentre de Diagnosi per la Imatge; Laboratorio de Referencia Sud; Centro OWLiverCompletedNon-Alcoholic Fatty Liver Disease | Visceral ObesitySpain
-
Inventiva PharmaActive, not recruitingDiabetes Mellitus, Type 2 | NASH - Nonalcoholic SteatohepatitisUnited States, Belgium, France, Netherlands, United Kingdom
-
Centre Hospitalier Universitaire DijonTerminatedType 2 DiabetesFrance
-
European Organisation for Research and Treatment...Active, not recruitingLymphomaFrance, Poland, Belgium, Netherlands, Slovenia, Italy, Egypt, Portugal, Germany
-
GenieBiome LimitedCompletedNon-Alcoholic Fatty Liver DiseaseHong Kong
-
Centre Hospitalier Universitaire DijonCompleted
-
Sunshine Lake Pharma Co., Ltd.CompletedNon-Alcoholic SteatohepatitisChina
-
Centre Hospitalier Universitaire DijonCompletedHepatic Steatosis | Pituitary Gland FailureFrance
-
Taipei City HospitalThe One Biopharmaceutical Co., Ltd.CompletedNon-alcoholic Fatty Liver Disease | Liver Fibrosis | Liver InjuryTaiwan
-
Ewha Womans University Mokdong HospitalCompletedNonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverKorea, Republic of
-
Arkansas Children's Hospital Research InstituteNational Institute of General Medical Sciences (NIGMS)CompletedHigh Intensity Interval Training | Insulin Resistance | Childhood Obesity | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Madrigal Pharmaceuticals, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Spain, Australia, United Kingdom, Canada, Israel, Belgium, Italy, France, Puerto Rico, Switzerland, Germany, Austria, Poland, Mexico, Hungary
-
PfizerCompletedHepatic Impairment | Healthy ParticipantsCzechia, Slovakia, Belgium
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingNonalcoholic Fatty Liver Disease | PhysicianUnited States
-
Bristol-Myers SquibbTerminatedNonalcoholic Steatohepatitis (NASH)United States, Germany, Taiwan, United Kingdom, Spain, Argentina, Brazil, France, Israel, Italy, Japan, Korea, Republic of, Belgium, Canada, Puerto Rico, Switzerland
-
89bio, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
Sisli Hamidiye Etfal Training and Research HospitalCompletedNAFLD | Obesity, ChildhoodTurkey
-
COD Research Private LtdCompletedFatty Liver Without Mention of AlcoholIndia
-
Chinese University of Hong KongTerminatedNon-alcoholic Fatty Liver DiseaseHong Kong
-
Fundación Pública Andaluza para la Investigación...CompletedMetabolic Syndrome | Insulin Resistance | Dyslipidemias | Hepatic Steatosis | Infant ObesitySpain
-
AdventHealth Translational Research InstituteActive, not recruitingNon-Alcoholic Fatty Liver DiseaseUnited States
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeTerminatedCardiovascular DiseasesUnited Kingdom
-
Sadat City UniversityActive, not recruitingFatty Liver, NonalcoholicEgypt
-
Duke UniversityTerminatedFatty LiverUnited States
-
Maastricht University Medical CenterPfizerCompleted
-
Hanyang UniversityNational Institute of Health, KoreaCompletedTime Restricted Feeding | Non-Alcoholic Fatty Liver Disease | Mobile TechnologyKorea, Republic of
-
Fundacion SEIMC-GESIDAActive, not recruiting
-
Hospital Clinic of BarcelonaInstitut d'Investigacions Biomèdiques August Pi i Sunyer; University of BarcelonaCompletedLiver Diseases | Non-Alcoholic Fatty Liver Disease | Lifestyle, HealthySpain
-
University Hospital OstravaActive, not recruiting
-
AstraZenecaParexelCompletedNon-alcoholic Steatohepatitis (NASH)United States
-
Shandong New Time Pharmaceutical Co., LTDCompletedEfficacy and SafetyChina
-
United Arab Emirates UniversityTawam HospitalCompletedCompensated Cirrhosis | Non-alcoholic Fatty Liver | Esophageal VaricesUnited Arab Emirates
-
University of Texas Southwestern Medical CenterEnrolling by invitationFatty LiverUnited States
-
Tanta UniversityActive, not recruitingNon-alcoholic SteatohepatitisEgypt
-
Zydus Therapeutics Inc.CompletedNonalcoholic Steatohepatitis | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Zydus Therapeutics Inc.CompletedNon Alcoholic SteatohepatitisUnited States
-
Shandong New Time Pharmaceutical Co., LTDCompletedA Phase IV Trial to Investigate the Efficacy and Safety of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty LiverChina
-
PerspectumFood and Drug Administration (FDA)CompletedNon-Alcoholic Fatty Liver DiseaseUnited States
-
Johannes Gutenberg University MainzGoethe UniversityCompletedDiabetes Mellitus, Type 2 | Hyperlipidemias | NASH - Nonalcoholic SteatohepatitisGermany
-
Johannes Gutenberg University MainzEnrolling by invitation
-
Baxter Healthcare CorporationCompletedEssential Fatty Acid Deficiency (EFAD)United States
-
University of California, San FranciscoUniversity of Colorado, Denver; The Methodist Hospital Research InstituteTerminatedEnd Stage Liver Disease | Chronic Kidney Diseases | Hepatitis B | Hepatocellular Carcinoma | Cirrhosis | Acute Kidney Injury | NASH - Nonalcoholic Steatohepatitis | Liver Transplant; Complications | Alcoholic Cirrhosis | Hepatitis cUnited States
-
Sagimet Biosciences Inc.CompletedCirrhosis | Hepatic Impairment | Non-alcoholic SteatohepatitisUnited States, Hungary
-
Sagimet Biosciences Inc.CompletedNonalcoholic Fatty Liver DiseaseUnited States, Canada, Puerto Rico, Poland